Literature DB >> 34956475

LncRNA MIAT promotes the proliferation, migration, and invasion of melanoma cells through recruiting TCF12 and activating NFAT5.

Fei Lu1, Ying Song2, Shuo Cui1, Huafei Zhao1, Yuhua Chen1, Hao Du3.   

Abstract

The present study aimed to explore the biological functions and mechanism of long non-coding RNA myocardial infarction-associated transcript (MIAT) in melanoma progression. MIAT expression in melanoma tissue samples and cells was detected by quantitative real-time PCR. After gain-of-function and loss-of-function models were constructed, cell counting kit-8, EdU, and Transwell assays were employed to detect the proliferation, migration, and invasion of melanoma cells. catRAPID database was employed and RNA pull-down assay and RNA immunoprecipitation assay were utilized to verify, the binding relationship between MIAT and transcription factor 12 (TCF12). The binding of TCF12 to the promoter region of the gene of nuclear factor of activated T cells 5 (NFAT5) was verified by chromatin immunoprecipitation-quantitative PCR assay and dual-luciferase reporter gene assay. The regulatory effects of MIAT and TCF12 on NFAT5 expression were detected via Western blot. The results showed that MIAT expression was increased in melanoma tissues and cells, and was significantly associated with the AJCC stage and the differentiation of melanoma tissues. MIAT overexpression markedly facilitated melanoma cells' multiplication, migration, and invasion, while MIAT knockdown inhibited the multiplication, migration, and invasion. MIAT showed direct interaction with TCF12. MIAT promoted the binding of TCF12 to NFAT5 promoter region, thereby promoting NFAT5 transcription. In conclusion, MIAT promotes melanoma progression through recruiting TCF12 and its interaction with NFAT5. AJTR
Copyright © 2021.

Entities:  

Keywords:  MIAT; NFAT5; TCF12; melanoma; migration; proliferation

Year:  2021        PMID: 34956475      PMCID: PMC8661192     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  28 in total

Review 1.  Melanoma.

Authors:  Dirk Schadendorf; Alexander C J van Akkooi; Carola Berking; Klaus G Griewank; Ralf Gutzmer; Axel Hauschild; Andreas Stang; Alexander Roesch; Selma Ugurel
Journal:  Lancet       Date:  2018-09-15       Impact factor: 79.321

Review 2.  bHLH factors in self-renewal, multipotency, and fate choice of neural progenitor cells.

Authors:  Itaru Imayoshi; Ryoichiro Kageyama
Journal:  Neuron       Date:  2014-04-02       Impact factor: 17.173

3.  LncRNA EMX2OS, Regulated by TCF12, Interacts with FUS to Regulate the Proliferation, Migration and Invasion of Prostate Cancer Cells Through the cGMP-PKG Signaling Pathway.

Authors:  Zhiqiang Wang; Chaowei Zhang; Junkai Chang; Xin Tian; Chaoyang Zhu; Weibo Xu
Journal:  Onco Targets Ther       Date:  2020-07-21       Impact factor: 4.147

Review 4.  Melanoma: Where we are and where we go.

Authors:  Ali Mohammadpour; Maryam Derakhshan; Hassan Darabi; Pegah Hedayat; Mohammad Momeni
Journal:  J Cell Physiol       Date:  2018-10-26       Impact factor: 6.384

5.  Long non-coding RNA MIAT promotes the growth of melanoma via targeting miR-150.

Authors:  Lifei Zhu; Yexiao Wang; Chaoying Yang; Yanchang Li; Zhixin Zheng; Liangcai Wu; Hui Zhou
Journal:  Hum Cell       Date:  2020-04-16       Impact factor: 4.374

6.  Effect of thioridazine on antioxidant status of HEMn-DP melanocytes.

Authors:  Michał Otręba; Artur Beberok; Dorota Wrześniok; Jakub Rok; Ewa Buszman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-06-24       Impact factor: 3.000

Review 7.  Revealing protein-lncRNA interaction.

Authors:  Fabrizio Ferrè; Alessio Colantoni; Manuela Helmer-Citterich
Journal:  Brief Bioinform       Date:  2015-06-02       Impact factor: 11.622

8.  Stromal miR-200s contribute to breast cancer cell invasion through CAF activation and ECM remodeling.

Authors:  X Tang; Y Hou; G Yang; X Wang; S Tang; Y-E Du; L Yang; T Yu; H Zhang; M Zhou; S Wen; L Xu; M Liu
Journal:  Cell Death Differ       Date:  2015-06-12       Impact factor: 15.828

Review 9.  LncRNA-mediated regulation of cell signaling in cancer.

Authors:  W-X Peng; P Koirala; Y-Y Mo
Journal:  Oncogene       Date:  2017-06-12       Impact factor: 9.867

10.  Comprehensive Analysis of a Competing Endogenous RNA Network Identifies Seven-lncRNA Signature as a Prognostic Biomarker for Melanoma.

Authors:  Nian Liu; Zijian Liu; Xinxin Liu; Hongxiang Chen
Journal:  Front Oncol       Date:  2019-10-03       Impact factor: 6.244

View more
  3 in total

1.  The expression level of chicken telomerase reverse transcriptase in tumors induced by ALV-J is positively correlated with methylation and mutation of its promoter region.

Authors:  Yong Xiang; Qinxi Chen; Qingbo Li; Canxin Liang; Weisheng Cao
Journal:  Vet Res       Date:  2022-06-23       Impact factor: 3.829

2.  The Prognostic Value of lncRNA MCM3AP-AS1 on Clinical Outcomes in Various Cancers: A Meta- and Bioinformatics Analysis.

Authors:  Liangyin Fu; Guangming Zhang; Yongfeng Wang; Tingting Lu; Bin Liu; Yajun Jiao; Haizhong Ma; Shixun Ma; Kehu Yang; Hui Cai
Journal:  Dis Markers       Date:  2022-06-24       Impact factor: 3.464

3.  A novel necroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma.

Authors:  Jianguo Wang; Bingbing Shen; Xinyuan Liu; Jianxin Jiang
Journal:  Front Genet       Date:  2022-10-04       Impact factor: 4.772

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.